BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8936957)

  • 1. The changes in serum type I and III procollagen, insulin-like growth factor-I and insulin-like growth factor binding protein-3 levels in children with chronic renal failure.
    Cinaz P; Buyan N; Gökçora N; Elbe S; Hasanoğlu E
    J Trop Pediatr; 1996 Oct; 42(5):271-5. PubMed ID: 8936957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in serum type I and III procollagen levels in children with chronic renal failure.
    Cinaz P; Buyan N; Gökçora N; Elbeg S; Hasanoğlu E
    Nephron; 1996; 72(2):189-91. PubMed ID: 8684525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of type I procollagen C-terminal propeptide, insulin-like growth factor-I (IGF-I), and IGF binding protein-3 in obese children and adolescents: relationship to gender, pubertal development, growth, insulin, and nutritional status.
    Falorni A; Bini V; Cabiati G; Papi F; Arzano S; Celi F; Sanasi M
    Metabolism; 1997 Aug; 46(8):862-71. PubMed ID: 9258266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor-I (IGF-I), insulin-like growth factor binding proteins (IGFBP) and insulin-like growth factor type I receptor in children with various status of chronic renal failure.
    Houang M; Cabrol S; Perin L; Ducos B; Bensman A; Le Bouc Y
    Growth Horm IGF Res; 2000 Dec; 10(6):332-41. PubMed ID: 11161964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5 in children with chronic renal failure: relationship to growth and glomerular filtration rate. The European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood. German Study Group for Growth Hormone Treatment in Chronic Renal Failure.
    Ulinski T; Mohan S; Kiepe D; Blum WF; Wingen AM; Mehls O; Tönshoff B
    Pediatr Nephrol; 2000 Jul; 14(7):589-97. PubMed ID: 10912524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
    Jehle PM; Ostertag A; Schulten K; Schulz W; Jehle DR; Stracke S; Fiedler R; Deuber HJ; Keller F; Boehm BO; Baylink DJ; Mohan S
    Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of carboxyterminal propeptide of type I procollagen and aminoterminal propeptide of type III procollagen in children with growth retardation.
    Cinaz P; Hasanoglu E; Gökçora N; Dogukan S; Demir A
    Mater Med Pol; 1994; 26(2):55-8. PubMed ID: 7745984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in serum levels of IGF-I and IGFBP-3 in children with chronic renal failure.
    Buyan N; Cinaz P; Hasanoğlu E; Gökçora N; Bircan Z
    Endocr J; 1995 Jun; 42(3):429-33. PubMed ID: 7545506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum insulin-like growth factors (IGFs) and IGF binding proteins 1, 2, and 3 in children with chronic renal failure: relationship to height and glomerular filtration rate. The European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood.
    Tönshoff B; Blum WF; Wingen AM; Mehls O
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2684-91. PubMed ID: 7545697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propeptide levels of type III and type I procollagen in the serum and bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis.
    Lammi L; Kinnula V; Lähde S; Risteli J; Pääkkö P; Lakari E; Ryhänen L
    Eur Respir J; 1997 Dec; 10(12):2725-30. PubMed ID: 9493651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor-1, growth hormone-dependent insulin-like growth factor-binding protein and growth in children with chronic renal failure.
    Hodson EM; Brown AS; Roy LP; Rosenberg AR
    Pediatr Nephrol; 1992 Sep; 6(5):433-8. PubMed ID: 1280988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between insulin-like growth factor 1 (IGF-1), IGF-binding proteins (IGFBPs), and the carboxyterminal propeptide of type I procollagen (PICP) in pre- and postmenopausal women with rheumatoid arthritis.
    Szeremeta A; Jura-Półtorak A; Komosińska-Vassev K; Zoń-Giebel A; Kapołka D; Olczyk K
    Scand J Rheumatol; 2017 May; 46(3):171-179. PubMed ID: 27775453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor-binding protein-6 levels are elevated in serum of children with chronic renal failure: a report of the Southwest Pediatric Nephrology Study Group.
    Powell DR; Liu F; Baker BK; Hintz RL; Durham SK; Brewer ED; Frane JW; Tonshoff B; Mehls O; Wingen AM; Watkins SL; Hogg RJ; Lee PD
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2978-84. PubMed ID: 9284730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure.
    Frystyk J; Ivarsen P; Skjaerbaek C; Flyvbjerg A; Pedersen EB; Orskov H
    Kidney Int; 1999 Dec; 56(6):2076-84. PubMed ID: 10594783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of chronic renal failure and growth hormone on serum levels of insulin-like growth factor-binding protein-4 (IGFBP-4) and IGFBP-5 in children: a report of the Southwest Pediatric Nephrology Study Group.
    Powell DR; Durham SK; Brewer ED; Frane JW; Watkins SL; Hogg RJ; Mohan S
    J Clin Endocrinol Metab; 1999 Feb; 84(2):596-601. PubMed ID: 10022422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth retardation in constitutionally short children is related both to low serum levels of insulin-like growth factor-I and to its reduced bioavailability.
    Lindgren BF; Segovia B; Lassarre C; Binoux M; Gourmelen M
    Growth Regul; 1996 Sep; 6(3):158-64. PubMed ID: 8894649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation.
    Juul A; Dalgaard P; Blum WF; Bang P; Hall K; Michaelsen KF; Müller J; Skakkebaek NE
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2534-42. PubMed ID: 7543116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased bioavailability of insulin-like growth factor-I, a cause of catabolism in hemodialysis patients?
    Lindgren BF; Odar-Cederlöf I; Ericsson F; Brismar K
    Growth Regul; 1996 Sep; 6(3):137-43. PubMed ID: 8894646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma levels of insulin-like growth factor binding protein-4 (IGFBP-4) under normal and pathological conditions.
    Van Doorn J; Cornelissen AJ; Van Buul-Offers SC
    Clin Endocrinol (Oxf); 2001 May; 54(5):655-64. PubMed ID: 11380497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collagen formation and degradation increase during growth hormone therapy in children.
    Vihervuori E; Turpeinen M; Siimes MA; Koistinen H; Sorva R
    Bone; 1997 Feb; 20(2):133-8. PubMed ID: 9028537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.